HRT Financial’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

HRT Financial’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,566	Closed	-$5K	–	3664
2023 Q1	$5K	Buy	+30,566	New	+$17K	﹤0.01%	2302
2021 Q2	–	Sell	-11,961	Closed	-$180K	–	3745
2021 Q1	$180K	Buy	+11,961	New	+$260K	﹤0.01%	2338

HRT Financial's CDAK Position: Q2 2023 in Review

HRT Financial sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2023, closing a stake of 30,566 shares — an estimated $5K sold.

HRT Financial first reported a position in CDAK in Q1 2021 and held it in 2 quarters. The position peaked at $180K in Q1 2021. 1 fund tracked by Wall St. Rank holds CDAK as of Q2 2023.

HRT Financial reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
HRT Financial sold 30,566 Codiak BioSciences, Inc. Common Stock shares in Q2 2023, an estimated $5K.
HRT Financial first reported a position in Codiak BioSciences, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
HRT Financial's Codiak BioSciences, Inc. Common Stock position peaked at $180K in Q1 2021.
1 fund tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.